These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 27820798)

  • 21. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
    Huan Y; Jiang Q; Liu JL; Shen ZF
    J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
    Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
    J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.
    Hollingsworth LR; Sharif H; Griswold AR; Fontana P; Mintseris J; Dagbay KB; Paulo JA; Gygi SP; Bachovchin DA; Wu H
    Nature; 2021 Apr; 592(7856):778-783. PubMed ID: 33731932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal degradation activates the NLRP1B inflammasome.
    Chui AJ; Okondo MC; Rao SD; Gai K; Griswold AR; Johnson DC; Ball DP; Taabazuing CY; Orth EL; Vittimberga BA; Bachovchin DA
    Science; 2019 Apr; 364(6435):82-85. PubMed ID: 30872531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The amino-dipeptidyl peptidases DPP8 and DPP9: Purification and enzymatic assays.
    Donzelli L; Bolgi O; Geiss-Friedlander R
    Methods Enzymol; 2023; 684():289-323. PubMed ID: 37230592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
    Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
    J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis.
    McKenzie BA; Mamik MK; Saito LB; Boghozian R; Monaco MC; Major EO; Lu JQ; Branton WG; Power C
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6065-E6074. PubMed ID: 29895691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.
    Coutts SJ; Kelly TA; Snow RJ; Kennedy CA; Barton RW; Adams J; Krolikowski DA; Freeman DM; Campbell SJ; Ksiazek JF; Bachovchin WW
    J Med Chem; 1996 May; 39(10):2087-94. PubMed ID: 8642568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CARD8 inflammasome activation triggers pyroptosis in human T cells.
    Linder A; Bauernfried S; Cheng Y; Albanese M; Jung C; Keppler OT; Hornung V
    EMBO J; 2020 Oct; 39(19):e105071. PubMed ID: 32840892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Inflammasome Drives GSDMD-Independent Secondary Pyroptosis and IL-1 Release in the Absence of Caspase-1 Protease Activity.
    Schneider KS; Groß CJ; Dreier RF; Saller BS; Mishra R; Gorka O; Heilig R; Meunier E; Dick MS; Ćiković T; Sodenkamp J; Médard G; Naumann R; Ruland J; Kuster B; Broz P; Groß O
    Cell Rep; 2017 Dec; 21(13):3846-3859. PubMed ID: 29281832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
    Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
    Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
    Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP induces caspase-3/gasdermin E-mediated pyroptosis in NLRP3 pathway-blocked murine macrophages.
    Zeng CY; Li CG; Shu JX; Xu LH; Ouyang DY; Mai FY; Zeng QZ; Zhang CC; Li RM; He XH
    Apoptosis; 2019 Oct; 24(9-10):703-717. PubMed ID: 31175486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
    Zhang H; Chen Y; Keane FM; Gorrell MD
    Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gossypol induces pyroptosis in mouse macrophages via a non-canonical inflammasome pathway.
    Lin QR; Li CG; Zha QB; Xu LH; Pan H; Zhao GX; Ouyang DY; He XH
    Toxicol Appl Pharmacol; 2016 Feb; 292():56-64. PubMed ID: 26765310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice.
    Waumans Y; Vliegen G; Maes L; Rombouts M; Declerck K; Van Der Veken P; Vanden Berghe W; De Meyer GRY; Schrijvers D; De Meester I
    Inflammation; 2016 Feb; 39(1):413-424. PubMed ID: 26454447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.
    Griswold AR; Ball DP; Bhattacharjee A; Chui AJ; Rao SD; Taabazuing CY; Bachovchin DA
    ACS Chem Biol; 2019 Nov; 14(11):2424-2429. PubMed ID: 31525884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.
    Yao TW; Kim WS; Yu DM; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD
    Mol Cancer Res; 2011 Jul; 9(7):948-59. PubMed ID: 21622624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.
    Jones B; Adams S; Miller GT; Jesson MI; Watanabe T; Wallner BP
    Blood; 2003 Sep; 102(5):1641-8. PubMed ID: 12738665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.